IRadimed Corporation Announces Strong Q3 2024 Financial Results

thank you for joining us today for the IRadimed Corporation Third Quarter 2024 Earnings Call. This session will provide insights into our financial performance and strategic direction. Earlier today, we published our financial results for the third quarter of 2024. The press release is accessible on our website and has been filed with the Securities and Exchange Commission.

Our discussion today will include forward-looking statements, which involve risks and uncertainties. Actual results may differ materially due to these factors, as detailed in our most recent SEC filings.

We are pleased to report a strong quarter, reflecting our commitment to innovation and operational excellence. Our financial performance underscores the successful execution of our strategic initiatives. We look forward to sharing more detailed insights into our results and future outlook during this call.

Now, I will hand over to Jack Glenn, our Chief Financial Officer, to provide a detailed financial overview.